Key Developments: Patterson Companies Inc (PDCO.O)

PDCO.O on Nasdaq

39.72USD
23 Jul 2014
Price Change (% chg)

$0.15 (+0.38%)
Prev Close
$39.57
Open
$39.70
Day's High
$39.85
Day's Low
$39.42
Volume
459,883
Avg. Vol
789,347
52-wk High
$44.39
52-wk Low
$36.59

Search Stocks

Latest Key Developments (Source: Significant Developments)

Patterson Companies announces planned retirement of executive vice president & CFO R. Stephen armstrong and appointment of Ann B. Gugino as successor
Tuesday, 10 Jun 2014 04:10pm EDT 

Patterson Companies Inc:Says that R. Stephen Armstrong, executive vice president and CFO, will step down at the end of Oct. 2014, after more than 15 years with the company.Ann B. Gugino, Patterson's vice president of strategy and planning, has been appointed vice president and CFO effective Nov. 1, 2014, reporting to chairman and CEO Scott P. Anderson.  Full Article

Patterson Companies Inc declares quarterly dividend
Tuesday, 10 Jun 2014 01:23pm EDT 

Patterson Companies Inc:Declares a quarterly cash dividend of $0.20 per share.Payable on July 25, to shareholders of record on July 11.  Full Article

Patterson Companies Inc gives FY 2015 EPS outlook below analysts' estimates
Thursday, 22 May 2014 07:00am EDT 

Patterson Companies Inc:Expects FY 2015 earnings in the range of $2.20 to $2.30 per diluted share.FY 2015 EPS of $2.38 - Thomson Reuters I/B/E/S.  Full Article

Patterson Companies Inc raises quarterly dividend
Tuesday, 18 Mar 2014 04:14pm EDT 

Patterson Companies Inc:Raises quarterly dividend from $0.16 to $0.20 per share.  Full Article

Patterson Companies Inc lowers high end of prior FY 2014 EPS guidance
Thursday, 20 Feb 2014 07:00am EST 

Patterson Companies Inc:Now expects FY 2014 earnings guidance range to $2.13 to $2.20 per diluted share.FY 2014 earnings guidance includes a $0.03 to $0.04 per diluted share contribution from the NVS acquisition.This guidance range excludes the non-recurring restructuring costs for Patterson Medical of about $0.12 per diluted share.FY 2014 EPS of $2.40 - Thomson Reuters I/B/E/S.  Full Article

Patterson Companies Inc declares quarterly dividend
Tuesday, 10 Dec 2013 04:00pm EST 

Patterson Companies Inc:Declares the quarterly cash dividend of $0.16 per share. The dividend will be payable on Jan. 24, 2014, to shareholders of record on Jan. 10, 2014.  Full Article

Patterson Companies Inc Reaffirms FY 2014 EPS Guidance
Thursday, 21 Nov 2013 07:00am EST 

Patterson Companies Inc reaffirmed fiscal 2014 earnings guidance to a range of $2.13 to $2.24 per diluted share (EPS), which includes the anticipated $0.03 to $0.04 per diluted share benefit from the NVS acquisition. The new guidance range excludes the non-recurring restructuring charge for Patterson Medical of approximately $0.12 per diluted share. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $2.17 for fiscal 2014. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $2.18 for fiscal 2014.  Full Article

Patterson Companies Inc Declares Quarterly Dividend
Tuesday, 10 Sep 2013 04:00pm EDT 

Patterson Companies Inc announced the quarterly cash dividend of $0.16 per diluted share. The dividend will be payable on October 25, 2013, to shareholders of record on October 11, 2013.  Full Article

Patterson Companies Inc Raises FY 2014 EPS Guidance
Thursday, 22 Aug 2013 07:00am EDT 

Patterson Companies Inc raised its fiscal 2014 earnings guidance to a range of $2.13 to $2.24 per diluted share (EPS), which includes the anticipated $0.03 to $0.04 per diluted share benefit from the NVS acquisition. The new guidance range excludes the non-recurring restructuring charge for Patterson Medical of approximately $0.12 per diluted share. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $2.17 for fiscal 2014.  Full Article

Patterson Companies Inc Completes Acquisition Of Dechra Pharmaceuticals PLC's National Veterinary Services
Friday, 16 Aug 2013 08:00am EDT 

Patterson Companies Inc announced that it has completed acquisition of the stock of National Veterinary Services Limited (NVS), a wholly owned subsidiary of Dechra Pharmaceuticals PLC (Dechra) (DPH.L). NVS is the veterinary distributor in the United Kingdom providing an array of products and services, including reference laboratory offerings. Financial terms of the transaction were not disclosed.  Full Article

Raptors nip Nets on Patterson's steal, hoop

NEW YORK -- Patrick Patterson hasn't played football since he was at Huntington High School in West Virginia, but the 6-foot-9 forward looked like a Pro Bowl defensive back in the waning seconds of the Toronto Raptors' 104-103 victory over the Brooklyn Nets on Monday night at the Barclays Center.

Search Stocks